Want to join the conversation?
$KNDI 2Q15 PR: Total revenues grew 45.5% to $48MM from $33MM for 2Q14; GAAP net income was $5.4MM, or approx. $0.12 per fully diluted share, compared to $11.2MM, or approx. $0.27 per diluted share in 2Q14. The decrease was mainly due to changes in stock-based compensation expenses and financial derivatives during the period.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.